ME

Marc Allan Eichmeyer

BO BOE: 25 patents #731 of 12,373Top 6%
Overall (All Time): #130,839 of 4,157,543Top 4%
29
Patents All Time

Issued Patents All Time

Showing 25 most recent of 29 patents

Patent #TitleCo-InventorsDate
10905756 Bivalent swine influenza virus vaccine Wesley Scott JOHNSON, Eric Martin Vaughn, Michelle L. Walz 2021-02-02
10767213 Quantification of vaccine compositions Michael B. Roof, Merrill Lynn Schaeffer, Eric Martin Vaughn, Kun Yang, Jeremy Richard Rush +1 more 2020-09-08
10624963 Multivalent PCV2 immunogenic compositions and methods of producing such compositions Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel 2020-04-21
10576142 PCV2 immunogenic compositions and methods of producing such compositions Gregory Paul Nitzel, Merrill Lynn Schaeffer 2020-03-03
10568955 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel, Merrill Lynn Schaeffer 2020-02-25
10029005 Bivalent swine influenza virus vaccine Wesley Scott JOHNSON, Eric Martin Vaughn, Michelle L. Walz 2018-07-24
9987349 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel, Merrill Lynn Schaeffer 2018-06-05
9925255 Multivalent PCV2 immunogenic compositions and methods of producing such compositions Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel 2018-03-27
9925256 Multivalent PCV2 immunogenic compositions and methods of producing such compositions Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel 2018-03-27
9919041 PCV2 immunogenic compositions and methods of producing such compositions Gregory Paul Nitzel, Merrill Lynn Schaeffer 2018-03-20
9669087 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel, Merrill Lynn Schaeffer 2017-06-06
9669086 PCV2 Mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions Michael B. Roof 2017-06-06
9624527 Quantification of vaccine compositions Michael B. Roof, Merrill Lynn Schaeffer, Eric Martin Vaughn, Kun Yang, Jeremy Richard Rush +1 more 2017-04-18
9610345 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Gregory Paul Nitzel, Merrill Lynn Schaeffer 2017-04-04
9561270 Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity Caroline Ann Kohler, Guosong Zhao, Ali Khazraeinazmpour, Bernd Colin Eichenmueller, Gregory HAIWICK +1 more 2017-02-07
9101561 Multivalent PCV2 immunogenic compositions and methods of producing such compositions Michael B. Roof, Phillip Wayne Hayes, Greg Nitzel 2015-08-11
9011868 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Greg Nitzel, Merrill Lynn Schaeffer 2015-04-21
9011872 PCV2 immunogenic compositions and methods of producing such compositions Gregory Paul Nitzel, Merrill Lynn Schaeffer 2015-04-21
8119143 Multivalent PCV2 immunogenic compositions and methods of producing such compositions Michael B. Roof, Phillip Wayne Hayes, Greg Nitzel 2012-02-21
8025888 PCV2 immunogenic compositions and methods of producing such compositions Greg Nitzel, Merrill Lynn Schaeffer 2011-09-27
7968285 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Greg Nitzel, Merrill Lynn Schaeffer 2011-06-28
7910306 PCV2 immunogenic compositions and methods of producing such compositions Greg Nitzel, Merrill Lynn Schaeffer 2011-03-22
7838213 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Greg Nitzel, Merrill Lynn Schaeffer 2010-11-23
7838214 Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs Michael B. Roof, Phillip Wayne Hayes, Greg Nitzel, Merrill Lynn Schaeffer 2010-11-23
7833707 Methods of overexpression and recovery of porcine circovirus type 2 ORF2 Greg Nitzel, Merrill Lynn Schaeffer 2010-11-16